Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Photosensitizer

DRUG CLASS:

Photosensitizer

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

EGFR mutation	Glioblastoma	EGFR mutation	Glioblastoma	verteporfin Sensitive: C2 – Inclusion Criteria verteporfin Sensitive : C2	verteporfin Sensitive: C2 – Inclusion Criteria verteporfin Sensitive : C2
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	bortezomib + verteporfin Sensitive: D – Preclinical bortezomib + verteporfin Sensitive : D	bortezomib + verteporfin Sensitive: D – Preclinical bortezomib + verteporfin Sensitive : D
EGFR amplification	Glioblastoma	EGFR amplification	Glioblastoma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
NF2 mutation	Mesothelioma	NF2 mutation	Mesothelioma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
LATS1 mutation	Mesothelioma	LATS1 mutation	Mesothelioma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
LATS2 mutation	Mesothelioma	LATS2 mutation	Mesothelioma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
RASSF7 amplification	Mesothelioma	RASSF7 amplification	Mesothelioma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
TP53 deletion + RB1 deletion + CTSK expression	Osteosarcoma	TP53 deletion + RB1 deletion + CTSK expression	Osteosarcoma	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D	verteporfin Sensitive: D – Preclinical verteporfin Sensitive : D
ROS1 rearrangement	Non Small Cell Lung Cancer	ROS1 rearrangement	Non Small Cell Lung Cancer	lorlatinib + verteporfin Sensitive: D – Preclinical lorlatinib + verteporfin Sensitive : D	lorlatinib + verteporfin Sensitive: D – Preclinical lorlatinib + verteporfin Sensitive : D